Digital Technologies Shake Up Arrhythmia Monitoring, Part 1: Apple’s New ECG-Enabled Watch—Gizmo or Game Changer?

article image
ARTICLE SUMMARY:

In Part 1 of this two-part article, we take a look at Apple’s new ECG enabled smart watch and the impact Apple’s entry into the arrhythmia monitoring market might have on consumers, physicians, and traditional medtech competitors.

Anyone attempting to forecast the impact that tech companies, and their consumer-focused, digitally connected offerings, might have on the future of healthcare delivery witnessed something of a watershed moment in mid-September when Apple Inc. announced its latest Series 4 Apple Watch.

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.


Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite

Questions?

We're here to help! Please contact us at: